~~<i id='6E59F98EF1'><strike id='6E59F98EF1'><tt id='6E59F98EF1'><pre id='6E59F98EF1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

comprehensive

author：focus 2025-10-01 18:32:23 - browse：3

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Amid AI frenzy, a top HHS official's quest to create safeguards

Wikipedia

leisure time

focus

hotspot

entertainment

Wikipedia

AdobePatientsoftenasktwoquestionsabouteverymedicaltreatment:Willithelpme?Willithurtme?TheFoodandDrug

WSS

What to make of Biden’s latest efforts on cancer research

Popular nasal decongestant doesn't actually relieve congestion

FDA panel endorses Alnylam’s heart drug — after picking it apart

First U.S. drug developed to treat liver disease MASH is approved

FDA approves updated Covid vaccines

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

hotspot

comprehensive

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

Pushing for an NIH office for post

Wildfire smoke exposes gaps in outdoor worker protections

How to make the FDA’s new prescription one

The cancer drug shortage isn’t new — and neither are the solutions

How housing is health care on Long Island

Bright Health sells Medicare Advantage business to Molina

Private equity could exacerbate cardiology's overuse problem, experts fear

Cancer drug shortages should be causing more outrage

Male and female sex labels in research insufficient, scientists say

leisure time

PEPFAR is under serious threat — and so is global health

How housing is health care on Long Island

EPA limits use of carcinogenic gas for sterilizing medical devices

EPA limits use of carcinogenic gas for sterilizing medical devices

IRA could hurt research into orphan drugs for rare diseases

Change Healthcare outage fallout shows need for new oversight

focus

hotspot

entertainment

Wikipedia